Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Cash flows from operating activities:
Net loss attributable to Flotek Industries, Inc. (Flotek)	$ (70,340,000)	$ (27,395,000)	$ (49,130,000)
Income (loss) from discontinued operations, net of tax	2,743,000	(9,891,000)	(44,683,000)
Loss from continuing operations	(73,083,000)	(17,504,000)	(4,447,000)
Adjustments to reconcile loss from continuing operations to net cash (used in) provided by operating activities:
Depreciation and amortization	9,216,000	9,768,000	8,172,000
Amortization of deferred financing costs	400,000	472,000	424,000
Provision for doubtful accounts	839,000	157,000	482,000
Provision for excess and obsolete inventory	2,418,000	388,000	0
Loss on sale of business	360,000	0	0
Loss on write-down of assets held for sale	2,580,000	0	0
(Gain) loss on sale of assets	(443,000)	292,000	(18,000)
Impairment of goodwill	37,180,000	0	0
Stock compensation expense	7,050,000	10,643,000	11,446,000
Deferred income tax (benefit) provision	(5,950,000)	181,000	(19,681,000)
Reduction in tax benefit related to share-based awards	709,000	1,989,000	2,510,000
Changes in current assets and liabilities:
Accounts receivable, net	(2,606,000)	4,076,000	(10,905,000)
Inventories	2,597,000	(3,442,000)	(1,463,000)
Income taxes receivable	(1,116,000)	8,008,000	(8,189,000)
Other current assets	3,177,000	12,001,000	(14,296,000)
Accounts payable	4,631,000	(8,528,000)	6,365,000
Accrued liabilities	(8,740,000)	(6,175,000)	32,769,000
Income taxes payable	0	0	(1,890,000)
Interest payable	(35,000)	19,000	(87,000)
Net cash (used in) provided by operating activities	(20,816,000)	12,345,000	1,192,000
Cash flows from investing activities:
Capital expenditures	(3,559,000)	(4,197,000)	(13,072,000)
Proceeds from sale of businesses	1,665,000	18,490,000	0
Proceeds from sale of assets	1,387,000	689,000	115,000
Payments for acquisitions, net of cash acquired	0	0	(7,863,000)
Purchase of patents and other intangible assets	(1,602,000)	(456,000)	(599,000)
Net cash (used in) provided by investing activities	(2,109,000)	14,526,000	(21,419,000)
Cash flows from financing activities:
Repayments of indebtedness	0	(9,833,000)	(15,564,000)
Borrowings on revolving credit facility	277,599,000	383,160,000	338,460,000
Repayments on revolving credit facility	(255,818,000)	(393,776,000)	(325,043,000)
Debt issuance costs	(111,000)	(579,000)	(1,199,000)
Reduction in tax benefit related to share-based awards	0	0	(2,510,000)
Purchase of treasury stock	(173,000)	(1,729,000)	(2,350,000)
Proceeds from sale of common stock	341,000	654,000	30,923,000
Repurchase of common stock	0	(5,203,000)	0
Proceeds from exercise of stock options	0	21,000	134,000
Loss from noncontrolling interest	(358,000)	0	0
Net cash provided by (used in) financing activities	21,480,000	(27,285,000)	22,851,000
Discontinued operations:
Net cash provided by operating activities	1,296,000	4,102,000	874,000
Net cash used in investing activities	(1,303,000)	(4,078,000)	(880,000)
Net cash flows (used in) provided by discontinued operations	(7,000)	24,000	(6,000)
Effect of changes in exchange rates on cash and cash equivalents	(88,000)	151,000	(3,000)
Net (decrease) increase in cash and cash equivalents	(1,540,000)	(239,000)	2,615,000
Cash and cash equivalents at beginning of year	4,584,000	4,823,000	2,208,000
Cash and cash equivalents at end of year	$ 3,044,000	$ 4,584,000	$ 4,823,000